A comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS)

Clinical and Experimental Allergy

Volumn 46, Issue 1, 2016, Pages 21-41

  Mahdavinia, M ^a   Keshavarzian, A ^a   Tobin, M C ^a   Landay, A L ^a   Schleimer, R P ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOST FACTOR;

ASTHMA; BACTERIUM CULTURE; BIOFILM; CHRONIC RHINOSINUSITIS; FUNGUS CULTURE; HEREDITY; HUMAN; MICROBIOME; MICROFLORA; NONHUMAN; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; UPPER RESPIRATORY TRACT; VIRUS DETECTION; ANIMAL; BACTERIUM; CHRONIC DISEASE; CLASSIFICATION; DISEASE PREDISPOSITION; FUNGUS; GENETIC PREDISPOSITION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; META ANALYSIS; METABOLISM; METAGENOME; METAGENOMICS; MICROBIOLOGY; NOSE MUCOSA; PHYSIOLOGY; RESPIRATORY MUCOSA; RHINITIS; SINUSITIS; VIRUS;

ANIMALS; ASTHMA; BACTERIA; BIOFILMS; CHRONIC DISEASE; DISEASE SUSCEPTIBILITY; FUNGI; GENETIC PREDISPOSITION TO DISEASE; HOST-PATHOGEN INTERACTIONS; HUMANS; METAGENOME; METAGENOMICS; MICROBIOTA; NASAL MUCOSA; RESPIRATORY MUCOSA; RHINITIS; SINUSITIS; STAPHYLOCOCCUS AUREUS; VIRUSES;

EID: 84955285476     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12666     Document Type: Review

References (151)

1. Anand VK. Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol Suppl 2004; 193:3-5.
2. Pleis JR, Ward BW, Lucas JW. Summary health statistics for U.S. adults: National Health Interview Survey, 2009. Vital and health statistics Series 10, Data from the National Health Survey 2010:1-207.
3. Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg 1995; 113:104-9.
4. Bachert C, Gevaert P, van Cauwenberge P. Staphylococcus aureus enterotoxins: a key in airway disease? Allergy 2002; 57:480-7.
5. Shin SH, Ponikau JU, Sherris DA et al. Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 2004; 114:1369-75.
6. Hosokawa T, Kikuchi Y, Nikoh N, Shimada M, Fukatsu T. Strict host-symbiont cospeciation and reductive genome evolution in insect gut bacteria. PLoS Biol 2006; 4:e337.
7. Nicholson JK, Holmes E, Kinross J et al. Host-gut microbiota metabolic interactions. Science 2012; 336:1262-7.
8. Sawa S, Lochner M, Satoh-Takayama N et al. RORgammat+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol 2011; 12:320-6.
9. Olszak T, An D, Zeissig S et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012; 336:489-93.
10. Hill DA, Siracusa MC, Abt MC et al. Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat Med 2012; 18:538-46.
11. Russell SL, Gold MJ, Hartmann M et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep 2012; 13:440-7.
12. Penders J, Gerhold K, Stobberingh EE et al. Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhood. J Allergy Clin Immunol 2013; 132:601-7 e608.
13. van Nimwegen FA, Penders J, Stobberingh EE et al. Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy. J Allergy Clin Immunol 2011; 128:948-55 e941-943.
14. Penders J, Stobberingh EE, van den Brandt PA, Thijs C. The role of the intestinal microbiota in the development of atopic disorders. Allergy 2007; 62:1223-36.
15. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9:313-23.
16. Ege MJ, Mayer M, Normand AC et al., Group GTS. Exposure to environmental microorganisms and childhood asthma. N Engl J Med 2011; 364:701-9.
17. Pakarinen J, Hyvarinen A, Salkinoja-Salonen M et al. Predominance of Gram-positive bacteria in house dust in the low-allergy risk Russian Karelia. Environ Microbiol 2008; 10:3317-25.
18. Lynch SV, Wood RA, Boushey H et al. Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children. J Allergy Clin Immunol 2014; 134:593-601 e512.
19. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299:1259-60.
20. von Mutius E, Radon K. Living on a farm: impact on asthma induction and clinical course. Immunol Allergy Clin North Am 2008; 28:631-47, ix-x.
21. van Strien RT, Engel R, Holst O et al. Microbial exposure of rural school children, as assessed by levels of N-acetyl-muramic acid in mattress dust, and its association with respiratory health. J Allergy Clin Immunol 2004; 113:860-7.
22. Sordillo JE, Hoffman EB, Celedon JC, Litonjua AA, Milton DK, Gold DR. Multiple microbial exposures in the home may protect against asthma or allergy in childhood. Clin Exp Allergy 2010; 40:902-10.
23. Debarry J, Garn H, Hanuszkiewicz A et al. Acinetobacter lwoffii and Lactococcus lactis strains isolated from farm cowsheds possess strong allergy-protective properties. J Allergy Clin Immunol 2007; 119:1514-21.
24. Hagner S, Harb H, Zhao M et al. Farm-derived Gram-positive bacterium Staphylococcus sciuri W620 prevents asthma phenotype in HDM- and OVA-exposed mice. Allergy 2013; 68:322-9.
25. Vogel K, Blumer N, Korthals M et al. Animal shed Bacillus licheniformis spores possess allergy-protective as well as inflammatory properties. J Allergy Clin Immunol 2008; 122:307-12, 312 e301-308.
26. Fujimura KE, Demoor T, Rauch M et al. House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection. Proc Natl Acad Sci USA 2014; 111:805-10.
27. Han MK, Huang YJ, Lipuma JJ et al. Significance of the microbiome in obstructive lung disease. Thorax 2012; 67:456-63.
28. Hilty M, Burke C, Pedro H et al. Disordered microbial communities in asthmatic airways. PLoS ONE 2010; 5:e8578.
29. Huang YJ, Nelson CE, Brodie EL et al., National Heart L, Blood Institute's Asthma Clinical Research N. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 2011; 127:372-81 e371-373.
30. Marri PR, Stern DA, Wright AL, Billheimer D, Martinez FD. Asthma-associated differences in microbial composition of induced sputum. J Allergy Clin Immunol 2013; 131:346-52 e341-343.
31. Goleva E, Jackson LP, Harris JK et al. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med 2013; 188:1193-201.
32. Legatzki A, Rosler B, von Mutius E. Microbiome diversity and asthma and allergy risk. Curr Allergy Asthma Rep 2014; 14:466.
33. Jiang RS, Liang KL, Jang JW, Hsu CY. Bacteriology of endoscopically normal maxillary sinuses. J Laryngol Otol 1999; 113:825-8.
34. Biel MA, Brown CA, Levinson RM et al. Evaluation of the microbiology of chronic maxillary sinusitis. Ann Otol Rhinol Laryngol 1998; 107:942-5.
35. Van Zele T, Gevaert P, Watelet JB et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 2004; 114:981-3.
36. Vossbrinck CR, Maddox JV, Friedman S, Debrunner-Vossbrinck BA, Woese CR. Ribosomal RNA sequence suggests microsporidia are extremely ancient eukaryotes. Nature 1987; 326:411-4.
37. Seshadri S, Rosati M, Lin DC et al. Regional differences in the expression of innate host defense molecules in sinonasal mucosa. J Allergy Clin Immunol 2013; 132:1227-30 e1225.
38. Yan M, Pamp SJ, Fukuyama J et al. Nasal microenvironments and interspecific interactions influence nasal microbiota complexity and S. aureus carriage. Cell Host Microbe 2013; 14:631-40.
39. Jiang RS, Hsu CY, Leu JF. Bacteriology of ethmoid sinus in chronic sinusitis. Am J Rhinol 1997; 11:133-7.
40. Chan J, Hadley J. The microbiology of chronic rhinosinusitis: results of a community surveillance study. Ear Nose Throat J 2001; 80:143-5.
41. Brook I, Frazier EH, Foote PA. Microbiology of chronic maxillary sinusitis: comparison between specimens obtained by sinus endoscopy and by surgical drainage. J Med Microbiol 1997; 46:430-2.
42. Kim HJ, Lee K, Yoo JB, Song JW, Yoon JH. Bacteriological findings and antimicrobial susceptibility in chronic sinusitis with nasal polyp. Acta Otolaryngol 2006; 126:489-97.
43. Benninger MS, Appelbaum PC, Denneny JC, Osguthorpe DJ, Stankiewicz JA. Maxillary sinus puncture and culture in the diagnosis of acute rhinosinusitis: the case for pursuing alternative culture methods. Otolaryngol Head Neck Surg 2002; 127:7-12.
44. Keech DR, Ramadan H, Mathers P. Analysis of aerobic bacterial strains found in chronic rhinosinusitis using the polymerase chain reaction. Otolaryngol Head Neck Surg 2000; 123:363-7.
45. Paju S, Bernstein JM, Haase EM, Scannapieco FA. Molecular analysis of bacterial flora associated with chronically inflamed maxillary sinuses. J Med Microbiol 2003; 52:591-7.
46. Power DA, Burton JP, Chilcott CN, Tagg JR, Dawes PJ. Non-culture-based analysis of bacterial populations from patients with chronic rhinosinusitis. J Clin Microbiol 2005; 43:5822-4.
47. Lewenza S, Charron-Mazenod L, Cho JJ, Mechor B. Identification of bacterial contaminants in sinus irrigation bottles from chronic rhinosinusitis patients. J Otolaryngol Head Neck Surg 2010; 39:458-63.
48. Stephenson MF, Mfuna L, Dowd SE et al. Molecular characterization of the polymicrobial flora in chronic rhinosinusitis. J Otolaryngol Head Neck Surg 2010; 39:182-7.
49. Stressmann FA, Rogers GB, Chan SW et al. Characterization of bacterial community diversity in chronic rhinosinusitis infections using novel culture-independent techniques. Am J Rhinol Allergy 2011; 25:e133-40.
50. Boase S, Foreman A, Cleland E et al. The microbiome of chronic rhinosinusitis: culture, molecular diagnostics and biofilm detection. BMC Infect Dis 2013; 13:210.
51. Feazel LM, Robertson CE, Ramakrishnan VR, Frank DN. Microbiome complexity and Staphylococcus aureus in chronic rhinosinusitis. Laryngoscope 2012; 122:467-72.
52. Aurora R, Chatterjee D, Hentzleman J, Prasad G, Sindwani R, Sanford T. Contrasting the microbiomes from healthy volunteers and patients with chronic rhinosinusitis. JAMA Otolaryngol Head Neck Surg 2013; 139:1328-38.
53. Abreu NA, Nagalingam NA, Song Y et al. Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis. Sci Transl Med 2012; 4:151ra124.
54. Choi EB, Hong SW, Kim DK et al. Decreased diversity of nasal microbiota and their secreted extracellular vesicles in patients with chronic rhinosinusitis based on a metagenomic analysis. Allergy 2014; 69:517-26.
55. Tetta C, Ghigo E, Silengo L, Deregibus MC, Camussi G. Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine 2013; 44:11-9.
56. Hong SW, Kim MR, Lee EY et al. Extracellular vesicles derived from Staphylococcus aureus induce atopic dermatitis-like skin inflammation. Allergy 2011; 66:351-9.
57. Bucholtz GA, Salzman SA, Bersalona FB et al. PCR analysis of nasal polyps, chronic sinusitis, and hypertrophied turbinates for DNA encoding bacterial 16S rRNA. Am J Rhinol 2002; 16:169-73.
58. Tan NC, Foreman A, Jardeleza C, Douglas R, Vreugde S, Wormald PJ. Intracellular Staphylococcus aureus: the Trojan horse of recalcitrant chronic rhinosinusitis? Int Forum Allergy Rhinol 2013; 3:261-6.
59. Ramakrishnan VR, Hauser LJ, Feazel LM, Ir D, Robertson CE, Frank DN. Sinus microbiota varies among chronic rhinosinusitis phenotypes and predicts surgical outcome. J Allergy Clin Immunol 2015; 136:334-42.e1. doi: 10.1016/j.jaci.2015.02.008. Epub 2015 Mar 26.
60. Ott SJ, Musfeldt M, Wenderoth DF et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004; 53:685-93.
61. Manichanh C, Rigottier-Gois L, Bonnaud E et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006; 55:205-11.
62. Payne SC, Benninger MS. Staphylococcus aureus is a major pathogen in acute bacterial rhinosinusitis: a meta-analysis. Clin Infect Dis 2007; 45:e121-7.
63. Sachse F, Becker K, Rudack C. Incidence of staphylococcal colonization and of the 753Q Toll-like receptor 2 variant in nasal polyposis. Am J Rhinol Allergy 2010; 24:e10-3.
64. Clark DW, Wenaas A, Citardi MJ, Luong A, Fakhri S. Chronic rhinosinusitis with nasal polyps: elevated serum immunoglobulin E is associated with Staphylococcus aureus on culture. Int Forum Allergy Rhinol 2011; 1:445-50.
65. Ramakrishnan VR, Feazel LM, Gitomer SA, Ir D, Robertson CE, Frank DN. The microbiome of the middle meatus in healthy adults. PLoS ONE 2013; 8:e85507.
66. Ramakrishnan VR, Feazel LM, Abrass LJ, Frank DN. Prevalence and abundance of Staphylococcus aureus in the middle meatus of patients with chronic rhinosinusitis, nasal polyps, and asthma. Int Forum Allergy Rhinol 2013; 3:267-71.
67. Sachse F, Becker K, von Eiff C, Metze D, Rudack C. Staphylococcus aureus invades the epithelium in nasal polyposis and induces IL-6 in nasal epithelial cells in vitro. Allergy 2010; 65:1430-7.
68. Soyka MB, Wawrzyniak P, Eiwegger T et al. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-gamma and IL-4. J Allergy Clin Immunol 2012; 130:1087-96 e1010.
69. Richer SL, Truong-Tran AQ, Conley DB et al. Epithelial genes in chronic rhinosinusitis with and without nasal polyps. Am J Rhinol 2008; 22:228-34.
70. Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001; 107:607-14.
71. Wang X, Zhang N, Glorieux S et al. Herpes simplex virus type 1 infection facilitates invasion of Staphylococcus aureus into the nasal mucosa and nasal polyp tissue. PLoS ONE 2012; 7:e39875.
72. Van Zele T, Gevaert P, Holtappels G et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol 2010; 125:1069-76 e1064.
73. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15:167-93.
74. Hekiert AM, Kofonow JM, Doghramji L et al. Biofilms correlate with TH1 inflammation in the sinonasal tissue of patients with chronic rhinosinusitis. Otolaryngol Head Neck Surg 2009; 141:448-53.
75. Foreman A, Psaltis AJ, Tan LW, Wormald PJ. Characterization of bacterial and fungal biofilms in chronic rhinosinusitis. Am J Rhinol Allergy 2009; 23:556-61.
76. Bendouah Z, Barbeau J, Hamad WA, Desrosiers M. Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis. Otolaryngol Head Neck Surg 2006; 134:991-6.
77. Psaltis AJ, Weitzel EK, Ha KR, Wormald PJ. The effect of bacterial biofilms on post-sinus surgical outcomes. Am J Rhinol 2008; 22:1-6.
78. Goldstein-Daruech N, Cope EK, Zhao KQ et al. Tobacco smoke mediated induction of sinonasal microbial biofilms. PLoS ONE 2011; 6:e15700.
79. Foreman A, Wormald PJ. Different biofilms, different disease? A clinical outcomes study Laryngoscope 2010; 120:1701-6.
80. Foreman A, Singhal D, Psaltis AJ, Wormald PJ. Targeted imaging modality selection for bacterial biofilms in chronic rhinosinusitis. Laryngoscope 2010; 120:427-31.
81. Chiu AG, Palmer JN, Woodworth BA et al. Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient. Am J Rhinol 2008; 22:34-7.
82. Isaacs S, Fakhri S, Luong A, Whited C, Citardi MJ. The effect of dilute baby shampoo on nasal mucociliary clearance in healthy subjects. Am J Rhinol Allergy 2011; 25:e27-9.
83. Farag AA, Deal AM, McKinney KA et al. Single-blind randomized controlled trial of surfactant vs hypertonic saline irrigation following endoscopic endonasal surgery. Int Forum Allergy Rhinol 2013; 3:276-80.
84. Ponikau JU, Sherris DA, Kern EB et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999; 74:877-84.
85. Braun H, Buzina W, Freudenschuss K, Beham A, Stammberger H. 'Eosinophilic fungal rhinosinusitis': a common disorder in Europe? Laryngoscope 2003; 113:264-9.
86. Hidir Y, Tosun F, Saracli MA, Gunal A, Gulec M, Yetiser S. Rate of allergic fungal etiology of chronic rhinosinusitis in Turkish population. Eur Arch Otorhinolaryngol 2008; 265:415-9.
87. Goh BS, Gendeh BS, Rose IM, Pit S, Samad SA. Prevalence of allergic fungal sinusitis in refractory chronic rhinosinusitis in adult Malaysians. Otolaryngol Head Neck Surg 2005; 133:27-31.
88. Sacks PL, Harvey RJ, Rimmer J, Gallagher RM, Sacks R. Topical and systemic antifungal therapy for the symptomatic treatment of chronic rhinosinusitis. Cochrane Database Syst Rev 2011; 2011:CD008263.
89. Ebbens FA, Scadding GK, Badia L et al. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 2006; 118:1149-56.
90. Cleland EJ, Bassioni A, Boase S, Dowd S, Vreugde S, Wormald PJ. The fungal microbiome in chronic rhinosinusitis: richness, diversity, postoperative changes and patient outcomes. Int Forum Allergy Rhinol 2014; 4:259-65.
91. Rank MA, Wollan P, Kita H, Yawn BP. Acute exacerbations of chronic rhinosinusitis occur in a distinct seasonal pattern. J Allergy Clin Immunol 2010; 126:168-9.
92. Cho GS, Moon BJ, Lee BJ et al. High rates of detection of respiratory viruses in the nasal washes and mucosae of patients with chronic rhinosinusitis. J Clin Microbiol 2013; 51:979-84.
93. Liao B, Hu CY, Liu T, Liu Z. Respiratory viral infection in the chronic persistent phase of chronic rhinosinusitis. Laryngoscope 2014; 124:832-7.
94. Jang YJ, Kwon HJ, Park HW, Lee BJ. Detection of rhinovirus in turbinate epithelial cells of chronic sinusitis. Am J Rhinol 2006; 20:634-6.
95. Wood AJ, Antoszewska H, Fraser J, Douglas RG. Is chronic rhinosinusitis caused by persistent respiratory virus infection? Int Forum Allergy Rhinol 2011; 1:95-100.
96. Wang JH, Kwon HJ, Chung YS, Lee BJ, Jang YJ. Infection rate and virus-induced cytokine secretion in experimental rhinovirus infection in mucosal organ culture: comparison between specimens from patients with chronic rhinosinusitis with nasal polyps and those from normal subjects. Arch Otolaryngol Head Neck Surg 2008; 134:424-7.
97. Yamin M, Holbrook EH, Gray ST et al. Cigarette smoke combined with Toll-like receptor 3 signaling triggers exaggerated epithelial regulated upon activation, normal T-cell expressed and secreted/CCL5 expression in chronic rhinosinusitis. J Allergy Clin Immunol 2008; 122:1145-53 e1143.
98. Jiang RS, Lin JF, Hsu CY. Correlation between bacteriology of the middle meatus and ethmoid sinus in chronic sinusitis. J Laryngol Otol 2002; 116:443-6.
99. Liu CM, Soldanova K, Nordstrom L et al. Medical therapy reduces microbiota diversity and evenness in surgically recalcitrant chronic rhinosinusitis. Int Forum Allergy Rhinol 2013; 3:775-81.
100. Kuczynski J, Lauber CL, Walters WA et al. Experimental and analytical tools for studying the human microbiome. Nat Rev Genet 2012; 13:47-58.
101. Woese CR, Fox GE. Phylogenetic structure of the prokaryotic domain: the primary kingdoms. Proc Natl Acad Sci USA 1977; 74:5088-90.
102. Huang YJ, Boushey HA. The microbiome in asthma. J Allergy Clin Immunol 2015; 135:25-30.
103. Specjalski K, Jassem E. Chlamydophila pneumoniae, Mycoplasma pneumoniae infections, and asthma control. Allergy Asthma Proc 2011; 32:9-17.
104. Martin RJ, Kraft M, Chu HW, Berns EA, Cassell GH. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001; 107:595-601.
105. Bisgaard H, Hermansen MN, Buchvald F et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 2007; 357:1487-95.
106. Jackson DJ, Gangnon RE, Evans MD et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008; 178:667-72.
107. Sigurs N, Aljassim F, Kjellman B et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 2010; 65:1045-52.
108. Kusel MM, de Klerk NH, Kebadze T et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007; 119:1105-10.
109. Kotaniemi-Syrjanen A, Vainionpaa R, Reijonen TM, Waris M, Korhonen K, Korppi M. Rhinovirus-induced wheezing in infancy-the first sign of childhood asthma? J Allergy Clin Immunol 2003; 111:66-71.
110. Park H, Shin JW, Park SG, Kim W. Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease. PLoS ONE 2014; 9:e109710.
111. Cardenas PA, Cooper PJ, Cox MJ et al. Upper airways microbiota in antibiotic-naive wheezing and healthy infants from the tropics of rural Ecuador. PLoS ONE 2012; 7:e46803.
112. van Woerden HC, Gregory C, Brown R, Marchesi JR, Hoogendoorn B, Matthews IP. Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study. BMC Infect Dis 2013; 13:69.
113. Green BJ, Wiriyachaiporn S, Grainge C et al. Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma. PLoS ONE 2014; 9:e100645.
114. Kellam P, Weiss RA. Infectogenomics: insights from the host genome into infectious diseases. Cell 2006; 124:695-7.
115. Nibali L, Henderson B, Sadiq ST, Donos N. Genetic dysbiosis: the role of microbial insults in chronic inflammatory diseases. J Oral Microbiol 2014; 6: 10.3402/jom.v6.22962.
116. Hsu J, Avila PC, Kern RC, Hayes MG, Schleimer RP, Pinto JM. Genetics of chronic rhinosinusitis: state of the field and directions forward. J Allergy Clin Immunol 2013; 131:977-93, 993 e971-975.
117. Zhang Y, Endam LM, Filali-Mouhim A, Bosse Y, Castano R, Desrosiers M. Polymorphisms in the nitric oxide synthase 1 gene are associated with severe chronic rhinosinusitis. Am J Rhinol Allergy 2011; 25:e49-54.
118. Ramanathan M Jr, Lee WK, Spannhake EW, Lane AP. Th2 cytokines associated with chronic rhinosinusitis with polyps down-regulate the antimicrobial immune function of human sinonasal epithelial cells. Am J Rhinol 2008; 22:115-21.
119. Mahdavinia M, Carter RG, Ocampo CJ et al. Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity. J Allergy Clin Immunol 2014; 133:1759-63.
120. Takabayashi T, Kato A, Peters AT et al. Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 2012; 130:410-20 e415.
121. Lane AP, Truong-Tran QA, Schleimer RP. Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps. Am J Rhinol 2006; 20:138-44.
122. Tieu DD, Kern RC, Schleimer RP. Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis. J Allergy Clin Immunol 2009; 124:37-42.
123. Wu X, Peters-Hall JR, Ghimbovschi S, Mimms R, Rose MC, Pena MT. Glandular gene expression of sinus mucosa in chronic rhinosinusitis with and without cystic fibrosis. Am J Respir Cell Mol Biol 2011; 45:525-33.
124. Schleimer RP, Kato A, Kern R, Kuperman D, Avila PC. Epithelium: at the interface of innate and adaptive immune responses. J Allergy Clin Immunol 2007; 120:1279-84.
125. Hiemstra PS. The role of epithelial beta-defensins and cathelicidins in host defense of the lung. Exp Lung Res 2007; 33:537-42.
126. Seshadri S, Lin DC, Rosati M et al. Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis. Allergy 2012; 67:920-8.
127. Glaser R, Harder J, Lange H, Bartels J, Christophers E, Schroder JM. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 2005; 6:57-64.
128. Tieu DD, Peters AT, Carter RG et al. Evidence for diminished levels of epithelial psoriasin and calprotectin in chronic rhinosinusitis. J Allergy Clin Immunol 2010; 125:667-75.
129. Woodworth BA, Lathers D, Neal JG et al. Immunolocalization of surfactant protein A and D in sinonasal mucosa. Am J Rhinol 2006; 20:461-5.
130. Lee HM, Kang HJ, Woo JS, Chae SW, Lee SH, Hwang SJ. Upregulation of surfactant protein A in chronic rhinosinusitis. Laryngoscope 2006; 116:328-30.
131. Vandermeer J, Sha Q, Lane AP, Schleimer RP. Innate immunity of the sinonasal cavity: expression of messenger RNA for complement cascade components and toll-like receptors. Arch Otolaryngol Head Neck Surg 2004; 130:1374-80.
132. Lane AP, Truong-Tran QA, Myers A, Bickel C, Schleimer RP. Serum amyloid A, properdin, complement 3, and toll-like receptors are expressed locally in human sinonasal tissue. Am J Rhinol 2006; 20:117-23.
133. Ramanathan M Jr, Lee WK, Dubin MG, Lin S, Spannhake EW, Lane AP. Sinonasal epithelial cell expression of toll-like receptor 9 is decreased in chronic rhinosinusitis with polyps. Am J Rhinol 2007; 21:110-6.
134. Lee RJ, Xiong G, Kofonow JM et al. T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection. J Clin Invest 2012; 122:4145-59.
135. Aujla SJ, Chan YR, Zheng M et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008; 14:275-81.
136. Zheng Y, Valdez PA, Danilenko DM et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008; 14:282-9.
137. Eidenschenk C, Rutz S, Liesenfeld O, Ouyang W. Role of IL-22 in microbial host defense. Curr Top Microbiol Immunol 2014; 380:213-36.
138. Taube C, Tertilt C, Gyulveszi G et al. IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease. PLoS ONE 2011; 6:e21799.
139. Stefka AT, Feehley T, Tripathi P et al. Commensal bacteria protect against food allergen sensitization. Proc Natl Acad Sci USA 2014; 111:13145-50.
140. Endam LM, Bosse Y, Filali-Mouhim A et al. Polymorphisms in the interleukin-22 receptor alpha-1 gene are associated with severe chronic rhinosinusitis. Otolaryngol Head Neck Surg 2009; 140:741-7.
141. Ramanathan M Jr, Spannhake EW, Lane AP. Chronic rhinosinusitis with nasal polyps is associated with decreased expression of mucosal interleukin 22 receptor. Laryngoscope 2007; 117:1839-43.
142. Detwiller KY, Smith TL, Alt JA, Trune DR, Mace JC, Sautter NB. Differential expression of innate immunity genes in chronic rhinosinusitis. Am J Rhinol Allergy 2014; 28:374-7.
143. Mattila E, Uusitalo-Seppala R, Wuorela M et al. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 2012; 142:490-6.
144. Wang ZK, Yang YS, Chen Y, Yuan J, Sun G, Peng LH. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J Gastroenterol 2014; 20:14805-20.
145. Cleland EJ, Drilling A, Bassiouni A, James C, Vreugde S, Wormald PJ. Probiotic manipulation of the chronic rhinosinusitis microbiome. Int Forum Allergy Rhinol 2014; 4:309-14.
146. Shi LL, Song J, Xiong P et al. Disease-specific T-helper cell polarizing function of lesional dendritic cells in different types of chronic rhinosinusitis with nasal polyps. Am J Respir Crit Care Med 2014; 190:628-38.
147. Poposki JA, Peterson S, Welch K et al. Elevated presence of myeloid dendritic cells in nasal polyps of patients with chronic rhinosinusitis. Clin Exp Allergy 2015; 45:384-93.
148. Schroeder JT. Basophils: emerging roles in the pathogenesis of allergic disease. Immunol Rev 2011; 242:144-60.
149. Shelburne CP, Abraham SN. The mast cell in innate and adaptive immunity. Adv Exp Med Biol 2011, 716:162-85.
150. Siraganian RP, Hook WA. Mechanism of histamine release by formyl methionine-containing peptides. J Immunol 1977; 119:2078-83.
151. Kouzaki H, O'Grady SM, Lawrence CB, Kita H. Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2. J Immunol 2009; 183:1427-34.